Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

Celgene Shareholders Excited by CAR-T News
Motley Fool
Tue, 12/19/17 - 08:10 pm
Tags:
Celgene, CAR-T, Bluebird Bio, bb2121
[video]ASH 2017 Recap: These Were the Big Winners and Losers
Motley Fool
Sat, 12/16/17 - 08:39 am
Tags:
ASH2017, Bluebird Bio, Juno Therapeutics, Spark Therapeutics, Biomarin, JNJ, Celgene
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
Wed, 12/13/17 - 09:36 am
Tags:
biotech, M&A, Biogen, Biomarin, Bluebird Bio, Geron, SAGE Therapeutics
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
Motley Fool
Mon, 12/11/17 - 10:02 am
Tags:
Bluebird Bio, bb2121, CAR-T, Celgene, Multiple Myeloma, ASH17
A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own
Forbes
Wed, 11/29/17 - 10:01 am
Tags:
gene therapy, drug manufacturing, Bluebird Bio
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
Tags:
ASH, Bluebird Bio, LentiGlobin, Ziopharm Oncology, Bellicum, BPX-501, Spark Therapeutics, SPK-8011, Biomarin, BMN 270, Juno Therapeutics, CAR-T, Novartis, Geron, imetelstat, Immunogen, IMGN632, IMGN779
Bluebird’s tweaked sickle cell gene therapy clears early test
Fierce Biotech
Wed, 11/1/17 - 06:42 pm
Tags:
Bluebird Bio, sickle cell disease, gene therapy, HGB-206
Bluebird’s gene therapy halts progression of ‘devastating’ disease cALD
Fierce Biotech
Fri, 10/6/17 - 09:48 am
Tags:
gene therapy, Bluebird Bio, cALD, Lenti-D
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
Tags:
biotech, Axovant Sciences, intepirdine, SAGE Therapeutics, brexanolone, AbbVie, risankizumab, Global Blood Therapeutics, GBT-440, DBV Technologies, Viaskin Peanut, Cytokinetics, Amicus Therapeutics, ATB200, Spark Therapeutics, Bluebird Bio, Revance Therapeutics, RT002
Why bluebird bio Inc Continued Its March Higher Again Today
Motley Fool
Thu, 08/31/17 - 10:13 pm
Tags:
Bluebird Bio, bb2121, CAR-T, Novartis, Kymriah, Gilead Sciences, Kite Pharma
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Motley Fool
Mon, 08/28/17 - 10:26 pm
Tags:
Bluebird Bio, Juno Therapeutics, Gilead Sciences, Kite Pharma, CAR-T, M&A
Is This Why bluebird bio Dipped 10.5% in July?
Motley Fool
Wed, 08/9/17 - 09:35 am
Tags:
Bluebird Bio, gene therapy, bb2121
bluebird bio Pauses During 2017 Data Blitz
Motley Fool
Mon, 08/7/17 - 05:59 pm
Tags:
Bluebird Bio, gene therapy, earnings, ASH
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
Investors Business Daily
Fri, 07/14/17 - 08:07 am
Tags:
Novartis, CAR-T, CTL019, Kite Pharma, Bluebird Bio
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Motley Fool
Sun, 07/9/17 - 11:41 am
Tags:
Celgene, Juno Therapeutics, Acceleron, Bluebird Bio
Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?
Investors Business Daily
Sun, 07/2/17 - 10:07 am
Tags:
Celgene, Bluebird Bio, Kite Pharma, Juno Therapeutics, CAR-T, immuno-oncology, bb2121
Bluebird Bio: Too Much Good News?
Barron's
Sat, 07/1/17 - 09:31 am
Tags:
Bluebird Bio, bb2121, Celgene
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy
Fri, 06/23/17 - 09:46 am
Tags:
Bluebird Bio, LentiGlobin, gene therapy, clinical trials, beta-thalassemia
3 Top-Performing Biotech Stocks This Week
Motley Fool
Fri, 06/16/17 - 09:51 am
Tags:
biotech, Kite Pharma, KTE-C19, Bluebird Bio, CAR-T, Lexicon Pharmaceuticals
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Endpoints
Mon, 06/5/17 - 12:10 pm
Tags:
Bluebird Bio, BCMA, CAR-T, Multiple Myeloma, ASCO 2017, bb2121, Celgene

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.